Evidence map›Paper›PMID 31988347›Full record

ArticleBritish journal of cancer2020

Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation.

Diana Farhat, Sophie Léon, Sandra E Ghayad, Nicolas Gadot, Philippe Icard, Muriel Le Romancer, Nader Hussein, Hubert Lincet

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Role of Lipoic Acid in Testosterone Production in Males.The world journal of men's health · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Metabolic Strategies for Inhibiting Cancer Development.Advances in nutrition (Bethesda, Md.) · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Diana FarhatUniversité Lyon 1, Lyon, France.
Sophie LéonPlateforme Ex-Vivo, Département de Recherche Translationnelle et Innovation, SIRIC LYriCAN, INCa-DGOS-Inserm_12563, Centre Léon Bérard, Lyon, France.
Sandra E GhayadDepartment of Biology, Faculty of Science II, Lebanese University, Fanar, Lebanon.
Nicolas GadotPlateforme Anatomopathologie-Recherche, Département de Recherche Translationnelle et Innovation, Centre Léon Bérard, Lyon, France.
Philippe IcardNormandie Univ, UNICAEN, CHU de Caen Normandie, Unité de recherche BioTICLA INSERM U 119, 14000, Caen, France.
Muriel Le RomancerUniversité Lyon 1, Lyon, France.
Nader HusseinLebanese University, Faculty of Sciences, Cancer biology Stem Cells and Molecular Immunology, Hadath-Beirut, Lebanon.
Hubert LincetUniversité Lyon 1, Lyon, France. hubert.lincet@univ-lyon1.fr.
Inserm · FRLebanese University · LBCentre de Recherche en Cancérologie de Lyon · FRCentre Léon Bérard · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Caen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is the second most common cancer in the world. Despite advances in therapies, the mechanisms of resistance remain the underlying cause of morbidity and mortality. Lipoic acid (LA) is an antioxidant and essential cofactor in oxidative metabolism. Its potential therapeutic effects have been well documented, but its mechanisms of action (MOA) are not fully understood.

methodsThe aim of this study is to validate the inhibitory LA effect on the proliferation of various breast cancer cell lines and to investigate the MOA that may be involved in this process. We tested LA effects by ex vivo studies on fresh human mammary tumour samples.

resultsWe demonstrate that LA inhibits the proliferation and Akt and ERK signalling pathways of several breast cancer cells. While searching for upstream dysregulations, we discovered the loss of expression of IGF-1R upon exposure to LA. This decrease is due to the downregulation of the convertase, furin, which is implicated in the maturation of IGF-1R. Moreover, ex vivo studies on human tumour samples showed that LA significantly decreases the expression of the proliferation marker Ki67.

conclusionLA exerts its anti-proliferative effect by inhibiting the maturation of IGF-1R via the downregulation of furin.

Indexed as

Breast NeoplasmsCell ProliferationDown-RegulationFemaleFurinHumansReceptor, IGF Type 1Thioctic AcidTransfectionFurinIGF1R protein, humanReceptor, IGF Type 1Thioctic Acid

Identifiers

PMID31988347
PMCPMC7078196
OpenAlexW3002105244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.